Analyst Ratings for Avita Medical Ltd. (RCEL)

RCEL Rating Summary

RCEL Price Target Summary

* Over Last 12-Mos
  |   Expand Research on RCEL
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $12.00 (+19.2%) * Over Last 12-Mos
Rating Score: 8.8 / 10   Percentile Rank: 88%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/7/2026 BTIG
» Updated 8/19/2026
Ryan Zimmerman Upgrade Buy
(Neutral)
11.00
(7.00)
4.75
(10.07)
112% Details
5/15/2026 Lake Street
» Updated 8/28/2026
Frank Takkinen Upgrade Buy
(Hold)
12.00
(8.00)
4.36
(10.07)
130.96% Details